UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of
 
the Securities Exchange Act of 1934
 
Filed by the Registrant   x
Filed by a Party other than the Registrant   o
Check the appropriate box:
o
Preliminary Proxy Statement
o
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
o
Definitive Proxy Statement
x
Definitive Additional Materials
o
Soliciting Material Pursuant to §240.14a-12

 
RAPTOR PHARMACEUTICAL CORP.
(Name of Registrant as Specified In Its Charter)
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
 
Payment of Filing Fee (Check the appropriate box):
x
No fee required.
o
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
 
(1)
Title of each class of securities to which transaction applies:
 
 
 
 
(2)
Aggregate number of securities to which transaction applies:
 
 
 
 
(3)
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
 
 
 
 
(4)
Proposed maximum aggregate value of transaction:
 
 
 
 
(5)
Total fee paid:
 
 
 
o
Fee paid previously with preliminary materials.
o
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
 
(1)
Amount Previously Paid:
 
 
 
 
(2)
Form, Schedule or Registration Statement No.:
 
 
 
 
(3)
Filing Party:
 
 
 
 
(4)
Date Filed:
 
 
 
 
 
 


*** Exercise Your Right to Vote ***
Important Notice Regarding the Availability of Proxy Materials for the
Shareholder Meeting to Be Held on July 23, 2013.


RAPTOR PHARMACEUTICAL CORP.
Meeting Information
 
Meeting Type:  Annual Meeting
For holders as of:    May 31, 2013
Date:     July 23, 2013     Time:    8:00 AM PST
Location:  Raptor Pharmaceutical Corp.
                   5 Hamilton Landing, Suite 160
                   Novato, CA  94949
 
You are receiving this communication because you hold shares in the above named company.
 
This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).
 
We encourage you to access and review all of the important information contained in the proxy materials before voting.
 
See the reverse side of this notice to obtain proxy materials and voting instructions.
 
 

 
 
 

— Before You Vote —
How to Access the Proxy Materials

Proxy Materials Available to VIEW or RECEIVE:

1.  Notice & Proxy Statement          2.   Annual Report

How to View Online:

Have the information that is printed in the box marked by the arrow
 
à
XXXX XXXX XXXX XXXX
(located on the following page) and visit: www.proxyvote.com.
 
How to Request and Receive a PAPER or E-MAIL Copy:
 
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
 
1) BY INTERNET:        www.proxyvote.com
 
2) BY TELEPHONE:    1-800-579-1639
 
3) BY E-MAIL*:            sendmaterial@proxyvote.com
 
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow
à
XXXX XXXX XXXX XXXX
(located on the following page) in the subject line.
 
 
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before July 9, 2013 to facilitate timely delivery.
 

 
— How To Vote —
 
Please Choose One of the Following Voting Methods
 
 
Vote In Person:   If you choose to vote these shares in person at the meeting, you must request a "legal proxy." To do so, please follow the instructions at www.proxyvote.com or request a paper copy of the materials, which will contain the appropriate instructions. Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance.
 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow
à
XXXX XXXX XXXX XXXX
available and follow the instructions.
 
 
Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a voting instruction form.
 

Voting Items:

The Board of Directors recommends that you vote FOR the following:

1.
Election of Directors
 
Nominees:
 
 
01)     Christopher M. Starr
05)     Llew Keltner
 
02)     Raymond W. Anderson
06)     Erich Sager
 
03)     Suzanne L. Bruhn
07)     Vijay B. Samant
 
04)     Richard L. Franklin
08)     Timothy P. Walbert


The Board of Directors recommends that you vote FOR the following proposal(s):

2.
  Advisory vote to approve the compensation of the Company's Named Executive Officers.


3.
To ratify the appointment by the audit committee of the Board of Directors of Burr Pilger Mayer, Inc. as Raptor's independent registered public accounting firm for the year ending December 31, 2013.


4.
To approve the plan amendment to the Raptor Pharmaceutical Corp. 2010 Stock Incentive Plan.

 
NOTE: Such other business as may properly come before the meeting or any adjournment thereof.